Paul R. Caron
- Hepatology top 1%
- Hepatitis C virus research 4
- Molecular Biology top 1%
- DNA Repair Mechanisms 10
- Cancer therapeutics and mechanisms 7
- DNA and Nucleic Acid Chemistry 7
- Biochemical and Molecular Research 5
- Melanoma and MAPK Pathways 3
- Toxicology top 2%
- Transplantation top 5%
- Virology top 5%
-
- Bacterial Genetics and Biotechnology 5
-
- Computational Drug Discovery Methods 4
- Co-authors
- Mark A. MurckoStephen J. SmerdonKatrin RittingerStefano VoliniaAlastair AitkenLewis C. CantleyMichael B. YaffeHenrik Leffers
- Journals
- Nucleic Acids Research (6 papers)Proceedings of the National Academy of Sciences (4 papers)Cell (4 papers)
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
Paul R. Caron
38 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Hepatology 725
- Molecular Biology 4.0k
- Toxicology 113
- Transplantation 81
- Virology 127
Countries citing papers authored by Paul R. Caron
This map shows the geographic impact of Paul R. Caron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul R. Caron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul R. Caron more than expected).
Fields of papers citing papers by Paul R. Caron
This network shows the impact of papers produced by Paul R. Caron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul R. Caron. The network helps show where Paul R. Caron may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul R. Caron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 65 | |
| 2 | 2003 | 14 | |
| 3 | 2002 | 20 | |
| 4 | Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwindingbreakdown → | 1998 | 518 |
| 5 | 1998 | 169 | |
| 6 | 1997 | 239 | |
| 7 | The Structural Basis for 14-3-3:Phosphopeptide Binding Specificitybreakdown → | 1997 | 1378 |
| 8 | 1996 | 347 | |
| 9 | 1996 | 54 | |
| 10 | Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptidebreakdown → | 1996 | 554 |
| 11 | 1996 | 203 | |
| 12 | 1996 | 202 | |
| 13 | 1994 | 89 | |
| 14 | 1994 | 18 | |
| 15 | 1994 | 75 | |
| 16 | 1990 | 216 | |
| 17 | 1988 | 37 | |
| 18 | 1988 | 40 | |
| 19 | 1988 | 24 | |
| 20 | 1988 | 18 |
About Paul R. Caron
Paul R. Caron is a scholar working on Hepatology, Physiology, Virology, Molecular Biology and Molecular Medicine, having authored 40 papers that have together received 5.2k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (10 papers), Cancer therapeutics and mechanisms (7 papers), DNA and Nucleic Acid Chemistry (7 papers), Biochemical and Molecular Research (5 papers), Bacterial Genetics and Biotechnology (5 papers), Computational Drug Discovery Methods (4 papers), Hepatitis C virus research (4 papers) and Melanoma and MAPK Pathways (3 papers). The work is most often cited by research in Hepatology (725 citations), Molecular Biology (4.0k citations), Toxicology (113 citations), Transplantation (81 citations) and Virology (127 citations). Paul R. Caron has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Mark A. Murcko, Stephen J. Smerdon, Katrin Rittinger, Stefano Volinia, Alastair Aitken, Lewis C. Cantley, Michael B. Yaffe, Henrik Leffers, S.J. Gamblin and Keith P. Wilson. Their work appears in journals such as Nucleic Acids Research, Proceedings of the National Academy of Sciences, Cell, Journal of Biological Chemistry and Structure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.